[1] |
FOURNIER T,MEDJOUBI-N N,PORQUET D.Alpha-1-acid glycoprotein[J]. Biochim Biophys Acta,2000,1482(1-2):157-171.
|
[2] |
DENTE L,PIZZA M G,METSPALU A,et al.Structure and expression of the genes coding for human alpha 1-acid glycoprotein[J]. EMBO J,1987,6(8):2289-2296.
|
[3] |
SCHÖNFELD D L,RAVELLI R B,MUELLER U,et al. The 1.8-A crystal structure of alpha1-acid glycoprotein (Orosomucoid) solved by UV RIP reveals the broad drug-binding activity of this human plasma lipocalin[J]. J Mol Biol,2008,384(2):393-405.
|
[4] |
FERNANDES C L,LIGABUE-BRAUN R,VERLI H.Structural glycobiology of human α1-acid glycoprotein and its implications for pharmacokinetics and inflammation[J]. Glycobiology,2015,25(10):1125-1133.
|
[5] |
BALMAÑA M,GIMÉNEZ E,PUERTA A,et al. Increased α1-3 fucosylation of α-1-acid glycoprotein (AGP) in pancreatic cancer[J]. J Proteomics,2016,132:144-154.
|
[6] |
LUO Z,LEI H,SUN Y,et al.Orosomucoid,an acute response protein with multiple modulating activities[J]. J Physiol Biochem,2015,71(2):329-340.
|
[7] |
GAULDIE J,RICHARDS C,HARNISH D,et al. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells[J]. Proc Natl Acad Sci U S A,1987,84(20):7251-7255.
|
[8] |
CAI L,OYENIRAN C,BISWAS D D,et al.ORMDL proteins regulate ceramide levels during sterile inflammation[J]. J Lipid Res,2016,57(8):1412-1422.
|
[9] |
GEMELLI C,MARTELLO A,MONTANARI M,et al.The Orosomucoid 1 protein is involved in the vitamin D-mediated macrophage de-activation process[J]. Exp Cell Res,2013,319(20):3201-3213.
|
[10] |
KOMORI T,KAI H,SHIMOISHI K,et al.Up-regulation by clarithromycin of alpha (1)-acid glycoprotein expression in liver and primary cultured hepatocytes[J]. Biochem Pharmacol,2001,62(10):1391-1397.
|
[11] |
LAMBRINIDIS G,VALLIANATOU T,TSANTILI-KAKOULIDOU A.In vitro,in silico and integrated strategies for the estimation of plasma protein binding. A review[J]. Adv Drug Deliv Rev,2015,86:27-45.
|
[12] |
HOCHEPIED T,BERGER F G,BAUMANN H,et al.Alpha (1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties[J]. Cytokine Growth Factor Rev,2003,14(1):25-34.
|
[13] |
CAPERNA T J,SHANNON A E,STOLL M,et al.Regulation of alpha-1 acid glycoprotein synthesis by porcine hepatocytes in monolayer culture[J]. Domest Anim Endocrinol,2015,52:51-59.
|
[14] |
HOCHEPIED T,WULLAERT A,BERGER F G,et al.Overexpression of alpha (1)-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis[J]. Gut,2002,51(3):398-404.
|
[15] |
ZHANG S,MARK K S.α1-Acid glycoprotein induced effects in rat brain microvessel endothelial cells[J]. Microvasc Res,2012,84(2):161-168.
|
[16] |
GUNNARSSON P,LEVANDER L,PAHLSSON P,et al.The acute-phase protein alpha 1-acid glycoprotein (AGP) induces rises in cytosolic Ca2+ in neutrophil granulocytes via sialic acid binding immunoglobulin-like lectins (siglecs)[J]. FASEB J,2007,21(14):4059-4069.
|
[17] |
ATEMEZEM A,MBEMBA E,VASSY R,et al.Human alpha1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages[J]. Biochem J,2001,356(Pt 1):121-128.
|
[18] |
LEI H,SUN Y,LUO Z,et al.Fatigue-induced orosomucoid 1 acts on C-C chemokine receptor type 5 to enhance muscle endurance[J]. Sci Rep,2016,6: 18839.
|
[19] |
DIETRICH J W,LANDGRAFE G,FOTIADOU E H.TSH and thyrotropic agonists: key actors in thyroid homeostasis[J]. J Thyroid Res,2012,2012:351864.
|
[20] |
CAI L,OYENIRAN C,BISWAS D D,et al.ORMDL proteins regulate ceramide levels during sterile inflammation[J]. J Lipid Res,2016,57(8):1412-1422.
|
[21] |
SUN Y,YANG Y,QIN Z,et al.The acute-phase protein orosomucoid regulates food intake and energy homeostasis via leptin receptor signaling pathway[J]. Diabetes,2016,65(6):1630-1641.
|
[22] |
LEE Y S,CHOI J W,HWANG I,et al.Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation[J]. J Biol Chem,2010, 285(29):22174-22185.
|
[23] |
GABAY C,KUSHNER I.Acute-phase proteins and other systemic responses to inflammation[J]. N Engl J Med,1999,340(6):448-454.
|
[24] |
DE LUCA C G,PACHECO-PEREIRA C,AYDINOZ S,et al. Diagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis[J]. J Clin Sleep Med,2015,11(1):27-36.
|
[25] |
CIOFFI M,ROSA A D,SERAO R,et al.Laboratory markers in ulcerative colitis:current insights and future advances[J]. World J Gastrointest Pathophysiol,2015,6(1):13-22.
|
[26] |
THURNHAM D I,NORTHROP-CLEWES C A. Inflammation and biomarkers of micronutrient status[J]. Curr Opin Clin Nutr Metab Care,2016,19(6):458-463.
|
[27] |
WARD A M,COOPER E H,TURNER R,et al.Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes[J]. Br J Cancer,1977 ,35(2):170-178.
|
[28] |
FISCHER K,KETTUNEN J,WÜRTZ P,et al. Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17 345 persons[J]. PLoS Med,2014, 11(2): e1001606.
|
[29] |
CLYNE B,OLSHAKER J S.The C-reactive protein[J]. J Emerg Med,1999,17(6):1019-1025.
|
[30] |
XIAO K,SU L,YAN P,et al.α-1-Acid glycoprotein as a biomarker for the early diagnosis and monitoring the prognosis of sepsis[J]. J Crit Care,2015,30(4):744-751.
|